---
category: news
title: "Tonix Pharmaceuticals Completes Clinical Phase of PREVAIL Proof-of-Concept Study of TNX-102 SL for the Treatment of Fibromyalgia-Type Long COVID"
excerpt: "Topline Results Expected Third Quarter 2023 Long COVID Afflicts Approximately 19% of Patients Following COVID-191, and is Expected to be a Global Health Burden Fibromyalgia-Type Long COVID with Multi-"
publishedDateTime: 2023-08-07T11:00:00Z
originalUrl: "https://www.benzinga.com/pressreleases/23/08/g33596875/tonix-pharmaceuticals-completes-clinical-phase-of-prevail-proof-of-concept-study-of-tnx-102-sl-for"
webUrl: "https://www.benzinga.com/pressreleases/23/08/g33596875/tonix-pharmaceuticals-completes-clinical-phase-of-prevail-proof-of-concept-study-of-tnx-102-sl-for"
ampWebUrl: "https://www.benzinga.com/amp/content/33596875"
cdnAmpWebUrl: "https://www-benzinga-com.cdn.ampproject.org/c/s/www.benzinga.com/amp/content/33596875"
type: article
quality: 22
heat: 22
published: false

provider:
  name: Benzinga.com
  domain: benzinga.com

topics:
  - Computer Vision
  - AI

images:
  - url: "https://www.benzinga.com/next-assets/images/schema-image-default.png"
    width: 1043
    height: 1043
    isCached: true

secured: "5P+sxGTymHdHuNc4tVSPWos6IyU/1PNfW6co1SKUWDoISe7T/69Z7Etb7d3QbV6qqAfaFb9FhupLC9YcpNLFSNx8iOEe3VZ6WWZQHDpJel2X3lyTaeFQoXeZVw5MyjJQfV4bcQqnH5bYR3P61O331RI6v0uBYXSTOrX9m/AcimBaKfR4hFGkCxeY5dbzRVY6BZCL0fNBDLb5OuoNEyDNW2tfU8sH9vEXTPnrPavLOXMrPHPuGMMS1ElFfltkXiCpJ1oTt+p8sFeKZRglMux7HL2oDV7AH8fr8xeKFbAgsJlF23rjrT58GXZ+wQuwXkyfF7gCg1Nx4iA2fE1FpwKFQ3zJJcRu9Ki+DDn0LCanZQI=;A3QDx5fKamQG6Eo5n84/DQ=="
---

